The University of Chicago Header Logo

Connection

John Fung to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications John Fung has written about Drug Therapy, Combination.
John Fung
Connection Strength
0.874
Drug Therapy, Combination
  1. Limitations of current liver transplant immunosuppressive regimens: renal considerations. Hepatobiliary Pancreat Dis Int. 2017 Feb; 16(1):27-32.
    View in: PubMed
    Score: 0.122
  2. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation. 2017 Feb; 101(2):341-349.
    View in: PubMed
    Score: 0.122
  3. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl. 2003 Sep; 9(9):954-60.
    View in: PubMed
    Score: 0.048
  4. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transpl. 2002 Nov; 8(11):1007-13.
    View in: PubMed
    Score: 0.045
  5. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation. 2001 Sep 27; 72(6):1091-7.
    View in: PubMed
    Score: 0.042
  6. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol. 2001 Mar; 41(3):268-76.
    View in: PubMed
    Score: 0.040
  7. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. Transplant Proc. 2001 Feb-Mar; 33(1-2):1342-4.
    View in: PubMed
    Score: 0.040
  8. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl. 2000 Jul; 6(4):434-9.
    View in: PubMed
    Score: 0.039
  9. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation. 1998 Nov 27; 66(10):1395-8.
    View in: PubMed
    Score: 0.035
  10. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015 Jul; 99(7):1455-62.
    View in: PubMed
    Score: 0.027
  11. Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron. 1987; 46 Suppl 1:19-33.
    View in: PubMed
    Score: 0.015
  12. Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation. 2006 Dec 27; 82(12):1621-4.
    View in: PubMed
    Score: 0.015
  13. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006 Jan 12; 354(2):141-50.
    View in: PubMed
    Score: 0.014
  14. Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl. 2005 Nov; 11(11):1343-52.
    View in: PubMed
    Score: 0.014
  15. Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc. 2005 Mar; 37(2):923-6.
    View in: PubMed
    Score: 0.013
  16. Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
    View in: PubMed
    Score: 0.013
  17. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
    View in: PubMed
    Score: 0.012
  18. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int. 2003 May; 16(5):336-40.
    View in: PubMed
    Score: 0.012
  19. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc. 2002 Aug; 34(5):1651-2.
    View in: PubMed
    Score: 0.011
  20. Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc. 2002 Aug; 34(5):1968-9.
    View in: PubMed
    Score: 0.011
  21. Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy. 2002 Feb; 22(2):184-7.
    View in: PubMed
    Score: 0.011
  22. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.
    View in: PubMed
    Score: 0.011
  23. The long-term efficacy of multivisceral transplantation. Transplant Proc. 2000 Sep; 32(6):1219-20.
    View in: PubMed
    Score: 0.010
  24. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
    View in: PubMed
    Score: 0.009
  25. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. Transplant Proc. 1999 Feb-Mar; 31(1-2):646-7.
    View in: PubMed
    Score: 0.009
  26. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc. 1999 Feb-Mar; 31(1-2):1134.
    View in: PubMed
    Score: 0.009
  27. Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation. 1999 Jan 27; 67(2):266-72.
    View in: PubMed
    Score: 0.009
  28. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. Clin Transpl. 1999; 217-21.
    View in: PubMed
    Score: 0.009
  29. A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol. 1998 Dec; 160(6 Pt 1):1982-5; discussion 1985-6.
    View in: PubMed
    Score: 0.009
  30. Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc. 1998 Jun; 30(4):1257-60.
    View in: PubMed
    Score: 0.008
  31. Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1375-7.
    View in: PubMed
    Score: 0.008
  32. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997 Jan 27; 63(2):223-8.
    View in: PubMed
    Score: 0.008
  33. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
    View in: PubMed
    Score: 0.008
  34. Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc. 1996 Oct; 28(5):2757-8.
    View in: PubMed
    Score: 0.007
  35. Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc. 1996 Aug; 28(4):2119-20.
    View in: PubMed
    Score: 0.007
  36. Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. Transplant Proc. 1996 Jun; 28(3):1237-40.
    View in: PubMed
    Score: 0.007
  37. Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. Transplant Proc. 1996 Apr; 28(2):735.
    View in: PubMed
    Score: 0.007
  38. A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation. 1995 Feb 27; 59(4):485-90.
    View in: PubMed
    Score: 0.007
  39. A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc. 1995 Feb; 27(1):814-7.
    View in: PubMed
    Score: 0.007
  40. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2433-4.
    View in: PubMed
    Score: 0.006
  41. Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug; 25(4):2435.
    View in: PubMed
    Score: 0.006
  42. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol. 1993 Jul; 143(1):85-98.
    View in: PubMed
    Score: 0.006
  43. Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc. 1993 Feb; 25(1 Pt 1):669-72.
    View in: PubMed
    Score: 0.006
  44. Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron. 1987; 46 Suppl 1:56-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.